Stratedigm Announces the Commercial Launch of Its Most Advanced Flow Cytometer Platform to Date; the 18 Color 4 Laser S1000EXi  
9/18/2013 9:57:56 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN JOSE, Calif.--(BUSINESS WIRE)--Stratedigm announced the commercial launch of its S1000EXi flow cytometers on August 28, 2013. The “EXi” model offers Stratedigm’s most advanced technology to date and sets a new gold standard for high performance, benchtop analyzers. Architected based on the revolutionary EX model, the S1000EXi incorporates newly developed, patent pending second-generation Smart Detect™ and Laser Trimming™ technologies, enabling the detection of up to 18 colors with 4 lasers and unmatched dynamic range for low threshold and microparticle applications. The S1000EXi model also offers seamless integration with the industry’s most versatile and powerful high throughput automation line. “The S1000EXi embodies the culmination of a decade of patented and patent pending research in advanced optics, electronics, and fluidics in a compact and easy to use flow cytometer. Moving forward, Stratedigm plans to standardize all of it analyzers, including its entry-level models with its revolutionary second-generation Smart Detect™ technology. The S1000EXi model is available as an upgrade to all legacy S1000 instruments,” noted Shervin Javadi, Stratedigm’s chief executive officer.

Help employers find you! Check out all the jobs and post your resume.